Viewing Study NCT05413850

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:25 PM
Ignite Modification Date: 2026-01-02 @ 3:03 AM
Study NCT ID: NCT05413850
Status: RECRUITING
Last Update Posted: 2025-09-23
First Post: 2022-05-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Sponsor: Blue Earth Therapeutics Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
None Metastatic Castration-resistant Prostate Cancer View
None mCRPC View
None Urogenital Neoplasms View
None Prostatic Neoplasms View
None Prostatic Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PSMA View
None mCRPC View
None Prostate cancer View
None 177Lu rhPSMA-10.1 View
None 18F-rhPSMA-7.3 View
None BET-PSMA-121 View
None Blue Earth Therapeutics Limited View
None Radiohybrid View
None Radiopharmaceuticals View